Research Use Disclaimer

This disclaimer applies specifically to dosing protocol pages, reconstitution references, peptide-blend pages, peptide-stack pages, and research summaries published on TriedRx. It supplements — and is read alongside — our Medical Disclaimer and Editorial Policy.

1. Research and Educational Reference Only

The dosing protocols, reconstitution math, administration references, and cycle summaries on TriedRx describe what has been published in peer-reviewed research, reported in clinical trial registries, or documented in self-report community literature. They are presented as an organized educational reference for researchers, students, clinicians studying the literature, and informed readers.

They are not protocols for your personal use. They are not prescribed doses. They are not safety-assessed for any individual reader. TriedRx does not recommend, endorse, or authorize the use of any peptide protocol by any individual.

2. Peptides as Research Compounds

Most peptides described in TriedRx protocol pages are sold in the United States and elsewhere as "research chemicals" intended for in vitro and laboratory research use only. They are not approved for human consumption, are not manufactured to pharmaceutical standards unless specifically labeled as compounded or prescription products, and typically carry explicit labeling from vendors prohibiting human use.

The inclusion of a peptide on TriedRx does not indicate that the peptide is legal, safe, or appropriate for any particular use in any particular jurisdiction. Our coverage reflects that a body of scientific research exists about a compound, not that the compound has been cleared for use by readers.

3. Source of Protocol Ranges

Dose ranges shown on TriedRx are drawn from:

Published clinical trials — doses administered to human subjects under Institutional Review Board or equivalent oversight, in contexts described in the study.
Preclinical research — doses administered to animal models or in vitro systems. These are clearly labeled and are not directly translatable to human dosing.
Pharmacology and pharmacokinetic studies — characterizing absorption, distribution, metabolism, and excretion.
Documented self-report community data — labeled explicitly as such, with caveats about the absence of controlled methodology and the unreliability of community-reported outcomes.
Regulatory filings — prescribing information for approved peptides, where applicable.

A dose appearing on TriedRx carries the limitations of the study it came from: sample size, duration, population, route of administration, and concurrent conditions. Protocol ranges are not "averages of what works" — they are descriptions of what was studied.

4. Reconstitution Math and Calculators

Reconstitution arithmetic presented on TriedRx is standard dimensional analysis: peptide mass divided by solvent volume yields concentration; dose mass divided by concentration yields injection volume. These calculations do not account for vial overfill, peptide assay variability, solvent evaporation, or the accuracy of your syringe or scale. You are responsible for independently verifying any math before you rely on it, and for using calibrated equipment.

The use of reconstitution math to prepare an injection presupposes that the underlying peptide is of known identity, known purity, and known mass — none of which TriedRx can verify for the specific product you possess. Our vendor rankings describe testing outcomes for samples we purchased; they do not testify to the composition of your specific vial.

5. Administration, Route, and Injection Technique

References to subcutaneous, intramuscular, intranasal, oral, or other routes of administration reflect what has been described in the literature for that peptide. They are not instructions to administer anything to yourself or to another person. Injection, in particular, carries risks including infection, hematoma, nerve injury, inadvertent intravascular administration, hypersensitivity reactions, sterile abscess formation, and lipoatrophy or lipohypertrophy at injection sites. These risks are not hypothetical, and competent injection technique requires training that TriedRx is not providing.

6. Blends, Stacks, and Combinations

Pages covering peptide blends (multiple peptides in a single reconstitution) and peptide stacks (separate peptides administered in combination) describe combinations that have been used in research or reported in community literature. Combinations add pharmacologic complexity: each peptide's half-life, receptor profile, and side-effect spectrum interacts with the others, and the body of controlled research on combinations is substantially thinner than for single peptides. Nothing on a blend or stack page constitutes a recommendation to combine any compounds.

7. Legal and Regulatory Variability

Peptide legal status differs sharply by jurisdiction. A compound that is legal to possess for research purposes in one country may be a controlled substance in another. Import, export, and shipment are governed by additional regulations. Professional licensure — for medical doctors, pharmacists, veterinarians, dentists, and research scientists — adds yet another layer of obligations. Athletic governing bodies (including the World Anti-Doping Agency, major league sports organizations, and collegiate athletic associations) maintain separate prohibited-substance lists that may or may not overlap with regulatory schedules.

TriedRx does not provide legal advice and cannot opine on the legality of any compound for you in your jurisdiction. Determining applicable law — and complying with it — is your sole responsibility.

8. No Vendor Relationship

Protocol pages on TriedRx may reference our vendor rankings. These references summarize TriedRx's independent editorial ratings, which are based on aggregated publicly available third-party lab reports, transparency disclosures, reputation signals, and operational data — not on laboratory procedures conducted by TriedRx. They are not endorsements, sponsorships, affiliate relationships, or commercial placements. TriedRx accepts no payment or compensation from peptide vendors and declines vendor-offered free samples, paid placement, and sponsored content. See our Editorial Policy for the full methodology and independence framework.

9. Research-Reader Acknowledgment

By continuing to read any dosing protocol, reconstitution reference, blend page, or stack page on TriedRx, you acknowledge that:

You are at least 18 years of age and of sound mind.
You are reading this material as an informed researcher, clinician, student, or educated layperson studying the literature — not as a patient seeking treatment.
You have read and understood the TriedRx Medical Disclaimer.
You will not use this content as a substitute for consultation with a qualified, licensed healthcare professional.
You accept that protocols described here may be outdated, incomplete, or inapplicable to your situation, and you will verify and update against primary sources before any practical use.
You understand that peptide use carries material risks that TriedRx cannot comprehensively describe, and you accept full personal responsibility for your actions.

10. Limitation of Liability (Reaffirmed)

The limitation of liability described in our Medical Disclaimer applies in full to every protocol, blend, stack, reconstitution, and research-reference page. TriedRx, its authors, editors, reviewers, testing partners, and affiliates are not liable for any harm, loss, or damage arising from your use of this material. Your sole remedy is to cease using the site.

11. Amendments

TriedRx may update this Research Use Disclaimer at any time. Updates become effective when posted. The "Last updated" date below will reflect material changes. Continued use of the site after an update constitutes acceptance of the updated terms.

---

Related policies: Medical Disclaimer · Editorial Policy

Last updated: April 20, 2026